Tag: Medical Science Award

Peijie He | Medicine and Dentistry | Innovation Excellence Award

Published on by WSA Awards

Prof. Dr. Peijie He | Medicine and Dentistry | Innovation Excellence Award

ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

Professor Peijie He, MD, PhD, is a senior surgeon, clinician-scientist, and academic leader in laryngology and head & neck surgery at the Eye and ENT Hospital of Fudan University, Shanghai. As Chief Physician of the Division of Laryngology, his career integrates advanced clinical practice, translational research, and postgraduate medical education, with a sustained focus on function-preserving treatment strategies for laryngeal and hypopharyngeal diseases. His academic training spans China and South Korea, combining clinical otolaryngology with laser medicine and photodynamic therapy, which has shaped his distinctive interdisciplinary research profile. Professor He has made substantial contributions to minimally invasive laryngeal surgery, phonosurgery, and laser-based therapies, particularly the clinical application of CO₂ and KTP lasers, photodynamic therapy, and office-based interventions for vocal fold leukoplakia, papillomatosis, hemangioma, and early-stage laryngeal carcinoma. His work bridges clinical innovation with mechanistic research, elucidating oxidative stress, ROS-mediated pathways, and apoptosis mechanisms in laryngeal cancer cells, thereby strengthening the scientific foundation of modern laryngological treatments. He has authored and co-authored over 30 peer-reviewed international publications in leading journals such as The Laryngoscope, Journal of Voice, European Archives of Oto-Rhino-Laryngology, Lasers in Medical Science, and Oncology Letters, with multiple papers as corresponding author. His research is frequently cited and widely recognized within the otolaryngology community. Professor He has served as Principal Investigator on multiple competitive grants, including projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Health Commission, supporting both basic and clinically translational research.

Citation Metrics (Scopus)
600
500
300

100

Citations
602
Documents
52
h-index
14

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Dujiang Yang | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Dujiang Yang | Health Professions | Best Researcher Award

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China

Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.

Profile: ORCID

Featured Publications

  1. (2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.

  2. (2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.

  3. (2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.

  4. (2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.

 

Shaobing Hua | Medicine and Dentistry | Best Innovation Award

Published on by WSA Awards

Prof. Dr. Shaobing Hua | Medicine and Dentistry | Best Innovation Award

Hangzhou Dalton Biosciences Ltd | China

Prof. Dr. Shaobing Hua is a distinguished biomedical scientist and innovator whose career spans more than three decades of impactful contributions to molecular biology, therapeutic antibody discovery, and advanced diagnostic technologies. Trained as a molecular biologist with postdoctoral experience at leading U.S. research institutions, he has played a pivotal role in translating fundamental discoveries into clinically deployable solutions. His early work advanced the understanding of signal transduction, proteasome regulation, and gene expression in protozoan parasites, laying the foundation for subsequent research in therapeutic antibody platforms, which led to multiple U.S. and international patents for novel humanized antibodies and high-throughput screening methods. Prof. Hua is widely recognized for developing next-generation hybrid capture technologies and innovative HPV testing platforms that have transformed cervical cancer screening, particularly in resource-limited settings. Under his scientific leadership, DALTON BioSciences has introduced a suite of diagnostic products for cervical cancer, endometrial carcinoma, pre-eclampsia, and vaginitis, contributing to the health of nearly 30 million women. His portfolio includes over 30 peer-reviewed publications in journals such as Journal of Biological Chemistry, Clinical Cancer Research, Protein Science, and Oncogene, and several dozens of patents granted in the United States, China, and the PCT system. His work has been cited widely by researchers across molecular diagnostics, oncology, and immunotechnology. Throughout his career, Prof. Hua has collaborated extensively with major clinical institutions, including leading hospitals affiliated with Zhejiang University, Peking University, the Chinese Academy of Medical Sciences, and several provincial oncology centers. He has served in key roles in national research programs, including China’s 863 Program, national key research plans, and major public health initiatives focused on cervical cancer elimination. His contributions have significantly advanced women’s health diagnostics, strengthened public health infrastructures, and accelerated the global adoption of innovative molecular screening technologies. Prof. Hua’s research, leadership, and translational impact continue to shape the future of precision diagnostics and global health innovation.

Profile: ORCID

Featured Publications

Liu, S., Han, B., Jin, D. Q., Li, L. W., Ge, T. T., Shou, Y. J., Ye, J. M., Zhang, L., & Hua, S. B. (2025). Design and development of a target amplification-free microfluidic platform for multiplex nucleic acids detection: A new generation of hybrid capture immunoassay. Journal of Medical Virology.

Ding, L., Lin, Y. H., Azam, M., Sheridan, J., Wei, S., Gupta, G., Singh, R. K., Pauling, M. H., Chu, A., Tran, A., Yu, N., Hu, J., Wang, W., Long, H., Xiang, D., Zhu, L., & Hua, S. B. (2010). Generation of high-affinity fully human anti-human interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast. Protein Science, 19, 1957–1966.

Vaday, G. G., Hua, S. B., Peehl, D. M., Pauling, M. H., Lin, Y. H., Zhu, L., Lawrence, D. M., Foda, H. D., & Zucker, S. (2004). CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single-chain Fv antibodies. Clinical Cancer Research, 10, 5630–5639.

Xia, C., Ma, W., Wang, F., Hua, S. B., & Liu, M. (2001). Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene, 20, 5903–5907.

Xia, C., Bao, Z., Tabassam, F., Ma, W., Qiu, M., Hua, S. B., & Liu, M. (2000). GCIP, a novel human Grap2 and Cyclin D interacting protein, regulates E2F-mediated transcriptional activity. Journal of Biological Chemistry, 275, 20942–20948.

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Published on by WSA Awards

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Published on by WSA Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Mansoura University hospital, Egypt

Dr. Mohamed Balata is a dedicated and accomplished Egyptian general and colorectal surgeon affiliated with Mansoura University Hospital, Egypt. With a robust academic background and extensive clinical training, Dr. Balata has built a reputation in both surgical practice and academic teaching. His clinical interests primarily revolve around laparoscopic and minimally invasive colorectal surgeries, as well as emerging techniques in bariatric and laser-assisted procedures. Over the past decade, he has developed advanced surgical skills and contributed to significant peer-reviewed publications, reflecting a balance between academic research and clinical excellence. Dr. Balata currently serves as a Consultant and Lecturer at the Faculty of Medicine, Mansoura University, where he is actively involved in training medical students and residents. His contributions to international scientific literature and his award-winning research on rectocele repair underscore his commitment to evidence-based surgery. Known for his expertise in managing complex surgical cases and for his continuous participation in workshops and professional development courses, Dr. Balata demonstrates strong leadership in surgical education and innovation. His collaborative spirit, excellent communication skills, and drive for clinical research position him as a distinguished professional within the field of surgery, particularly in colorectal procedures and functional outcomes.

Professional Profile

Education

Dr. Mohamed Balata possesses a well-rounded educational background in general and colorectal surgery, obtained from one of Egypt’s leading medical institutions—Mansoura University. He earned his MD in General Surgery in December 2019, following a Master’s degree in the same specialty in September 2014. His academic journey began with obtaining a medical license from the Ministry of Health and Population in March 2011, which marked the formal start of his clinical career. Notably, in November 2009, he completed an MD Degree in General and Colorectal Surgery with an Excellent with Honors grade from the Faculty of Medicine, Mansoura University. This early academic distinction laid the foundation for a career steeped in clinical rigor and academic excellence. Dr. Balata’s education has been supplemented by his participation in numerous professional development workshops and certified training programs, including international publication courses and advanced laparoscopic surgery sessions. His continuous educational efforts reflect a commitment to lifelong learning and adapting to evolving surgical technologies. This foundation has enabled him to effectively translate theoretical knowledge into practical surgical proficiency and has paved the way for his progression into roles of higher academic and clinical responsibility.

Professional Experience

Dr. Mohamed Balata has accumulated over a decade of progressive clinical and academic experience in general and colorectal surgery. He currently serves as a Consultant and Lecturer at the General Surgery Department of Mansoura University Hospital, a position he has held since January 2020. His prior roles include Assistant Lecturer (2014–2020) and Teaching Assistant (2014) at the same institution. These academic appointments are complemented by his earlier clinical work, including his tenure as a Specialist of General Surgery at the Health Affairs Directorate under Egypt’s Ministry of Health. His surgical residency from 2011 to 2014 at Mansoura University Hospitals provided foundational experience in managing a diverse range of general surgical cases. Dr. Balata’s career also includes roles as a General Practitioner and completion of an internship year at Mansoura University Hospitals. Throughout these roles, he has not only refined his surgical skills but also demonstrated dedication to medical education by actively engaging in training medical students, surgical residents, and board-certified doctors. His teaching contributions, coupled with advanced clinical practice, reflect a strong dual commitment to both patient care and academic medicine, making him a well-rounded professional in the medical and surgical community.

Research Interest

Dr. Mohamed Balata’s research interests lie primarily in general and colorectal surgery, with a focused emphasis on minimally invasive and functional outcomes of surgical interventions. His work investigates the comparative effectiveness of various surgical approaches, including laparoscopic versus open procedures, and their impact on postoperative recovery and quality of life. One of his notable research contributions explored the functional and sexual quality of life following transperineal versus transvaginal repair of anterior rectocele, which was recognized internationally. Additionally, he has shown keen interest in stem cell applications for anal sphincter repair, manometric assessments in rectocele management, and innovations in pilonidal disease treatments, including laser techniques. Dr. Balata’s scholarly output reflects a clinical-research integration, where surgical decision-making is informed by empirical findings. His multidisciplinary approach includes collaboration with gastroenterology, gynecology, and radiology departments to deliver holistic patient care. He also explores surgical education and skill development through observational studies and clinical trials. His research not only advances surgical protocols but also contributes to academic literature and evidence-based guidelines, especially within the field of functional colorectal disorders. Dr. Balata remains committed to expanding this portfolio, aiming to improve patient outcomes and enhance surgical standards regionally and globally.

Research Skills

Dr. Mohamed Balata is equipped with a comprehensive suite of research skills that align with his clinical expertise in general and colorectal surgery. He has hands-on experience in designing and executing clinical trials, as evidenced by his randomized controlled study on rectocele repair outcomes. His methodological competencies include data analysis using SPSS and Stata, literature reviews, and manuscript preparation for peer-reviewed journals. Dr. Balata is well-versed in both qualitative and quantitative research techniques and is proficient in international scientific publishing. He has collaborated with interdisciplinary teams to explore various aspects of surgical innovation and patient care. His familiarity with ethical standards and research protocols ensures compliance in human subject research. Additionally, he possesses strong presentation and communication skills, having participated in international conferences and surgical workshops. He has the capability to translate complex clinical findings into practical applications, a trait that enhances his teaching and mentorship roles. Furthermore, his work in observational studies, surgical outcome measures, and patient quality of life assessments demonstrates a strong understanding of clinical research metrics. These research skills not only support his academic publications but also enable him to contribute meaningfully to evidence-based surgical practice and policy-making.

Awards and Honors

Dr. Mohamed Balata has received notable recognition for his contributions to surgical research and clinical excellence. Most prominently, he was awarded for the Best Publication by the American Society of Colon and Rectal Surgeons (ASCRS) in 2020. This prestigious accolade was granted for his study titled “Functional outcome and Sexual-Related Quality of Life after Transperineal versus Transvaginal Repair of Anterior Rectocele,” which was published in the Diseases of the Colon & Rectum journal. The award highlights not only the academic merit of his work but also its clinical relevance in advancing surgical practice. In addition to international recognition, Dr. Balata has consistently demonstrated academic excellence from his early education, including graduating with honors. His research continues to attract attention for its innovative approaches and direct impact on improving patient outcomes. These honors underscore his dedication to blending surgical expertise with rigorous academic inquiry. Furthermore, his active membership in the Egyptian Society of Surgeons and the Egyptian Group of Colorectal Surgeons positions him within key professional networks that support ongoing learning and recognition. These achievements validate Dr. Balata’s standing as a committed and impactful researcher in the medical and surgical fields.

Conclusion

Dr. Mohamed Balata stands out as a highly competent and research-driven colorectal surgeon who has successfully integrated clinical practice with academic scholarship. His robust educational foundation, combined with his professional experience in one of Egypt’s leading medical institutions, reflects both depth and breadth of expertise. Through his internationally recognized research, he has addressed critical aspects of surgical outcomes, quality of life, and minimally invasive techniques. His ability to conduct, publish, and present high-quality research underscores his capacity for independent investigation and scientific communication. Furthermore, Dr. Balata’s contributions as a lecturer and mentor indicate a commitment to shaping the next generation of surgeons. He consistently pursues academic excellence through workshops, professional society memberships, and participation in national and international forums. While his current achievements are substantial, opportunities for further interdisciplinary collaboration and grant acquisition could expand the reach and application of his work. In summary, Dr. Balata is a well-rounded academic surgeon who meets the criteria for the Best Researcher Award through his strong publication record, commitment to clinical innovation, and active involvement in surgical education and research. His profile exemplifies excellence in translational surgical science and continuous professional development.

Publications Top Notes

  1. Title: Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair on Gastroesophageal Reflux Disease in Patients with Severe Obesity: A Propensity Score-Matched Analysis

  2. Authors: El Nakeeb, Ayman M.; Aldossary, Hassan Maged; Zaid, Ahmed; Alnakeeb, Kareem; Attia, Mohamed Sabry

  3. Journal: Obesity Surgery: Including Laparoscopy and Allied Care

  4. Year: 2025

 

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Scientific Director of the Obesity Center of the Polytechnic University of Marche from Polytechnic University of Marche, Italy

Prof. Saverio Cinti is a distinguished researcher and academic in the field of obesity, adipose tissue physiology, and human anatomy. With over 35 years of experience in medical research and education, he has made groundbreaking contributions to the understanding of fat biology, metabolism, and obesity-related disorders. He has served as a Full Professor of Human Anatomy at Marche Polytechnic University and is currently the Scientific Director of the Obesity Center at the same institution. His prolific research output includes over 340 peer-reviewed publications, with an impressive H-index of 87 and 37,585 citations (Scopus), demonstrating his global influence in the scientific community. He has also authored books, contributed to over 20 book chapters, and holds multiple patents in the field of metabolic diseases. Prof. Cinti has been an invited speaker at prestigious institutions, including Harvard, Columbia, NIH, and the European Congress of Endocrinology. His contributions have been recognized with prestigious awards, such as the Blaise Pascal Medal and the Friedrich Wassermann Prize. As a pioneer in adipose tissue research, his work continues to shape the future of obesity treatment and metabolic health on an international scale.

Professional Profile

Education

Prof. Saverio Cinti’s academic journey began with a Doctor of Medicine (MD) degree from the University of Padua in 1974. He then pursued specialization in Internal Medicine at the University of Verona (1979) and Surgical Pathology at the University of Milan (1982). His advanced training provided him with a strong foundation in human anatomy, cellular biology, and pathology, which later became central to his research on obesity and adipose tissue. Over the years, he has continuously expanded his expertise, engaging in multidisciplinary medical research and international collaborations. His education has been complemented by extensive teaching experience, particularly in anatomy, histology, and obesity-related metabolic studies. His deep understanding of human anatomy and pathology has allowed him to bridge the gap between basic research and clinical applications. His affiliation with global institutions, including the University of Copenhagen and the University of Bonn, further highlights his role as a leading educator and researcher in the field. His academic background, combined with his dedication to continuous learning, has positioned him as a key figure in obesity and metabolic disorder research.

Professional Experience

Prof. Cinti has held several prominent academic and research positions over the past four decades. From 1984 to 2020, he was the Head of the Anatomy and Cell Biology Unit at the Department of Experimental and Clinical Medicine at Marche Polytechnic University. He served as a Full Professor of Human Anatomy from 1986 to 2020, where he played a crucial role in shaping medical education. His leadership extends beyond academia, as he has also been the Director of the Obesity Center at Marche Polytechnic University since 2011 and the Scientific Director of the Obesity Center since 2020. His international experience includes being an Affiliated Professor at the University of Copenhagen and a Distinguished Professor Emeritus at the University of Bonn. Additionally, he has served as the President of the Italian Society of Obesity (SIO) from 2008 to 2010. His long-standing involvement in clinical research and academic leadership has significantly contributed to advancements in obesity and adipose tissue research. His career is marked by extensive grant funding (~€2.5 million), numerous high-impact publications, and collaborative efforts in obesity and metabolic disease research.

Research Interest

Prof. Cinti’s research primarily focuses on adipose tissue biology, obesity mechanisms, and metabolic disorders. His work has provided crucial insights into the function, differentiation, and plasticity of adipocytes, particularly in relation to metabolic diseases such as diabetes and obesity. He has extensively studied the role of white, brown, and beige adipose tissue in energy metabolism and thermogenesis. His research also explores the cellular and molecular mechanisms of fat storage, lipid metabolism, and the impact of obesity on systemic health. A key aspect of his work involves understanding how adipose tissue dysfunction contributes to metabolic syndrome, cardiovascular diseases, and inflammation-related disorders. He has been actively involved in translational research, bridging laboratory discoveries with potential clinical applications for obesity treatment. His studies on leptin, irisin, and adipose-derived stem cells have contributed to the development of innovative therapies for metabolic diseases. Additionally, his research extends to regenerative medicine, focusing on adipose tissue engineering for tissue repair and renewal. His contributions continue to shape obesity research, paving the way for novel therapeutic approaches and a better understanding of adipose tissue biology.

Research Skills

Prof. Cinti possesses a diverse range of research skills, making him a leading authority in obesity and adipose tissue studies. He is highly skilled in electron microscopy, histological analysis, and molecular biology techniques, which he has used to investigate the structure and function of adipose tissues. His expertise in cellular and molecular biology has allowed him to make groundbreaking discoveries regarding adipocyte differentiation and metabolic regulation. He is proficient in animal models of obesity, metabolic syndrome, and diabetes, enabling him to conduct preclinical research on obesity treatments. His work also involves biochemical assays, gene expression analysis, and imaging techniques to study fat metabolism and energy homeostasis. Additionally, he has experience in clinical research methodologies, including patient-based studies on obesity, metabolic disorders, and regenerative medicine. His strong background in scientific writing and peer reviewing has led to contributions in top-tier journals such as Nature, Science, and Cell Metabolism. His ability to integrate basic science with clinical applications has made him a pioneer in translational obesity research.

Awards and Honors

Prof. Cinti has received numerous prestigious awards in recognition of his contributions to obesity research. In 2008, he was awarded the Blaise Pascal Medal by the European Academy of Science, a prestigious honor for his pioneering work in metabolic diseases. In 2013, he received the Friedrich Wassermann Prize from the European Association for the Study of Obesity (EASO), further highlighting his impact on obesity research. He has also been honored as a Distinguished Professor Emeritus at the University of Bonn and has been a plenary speaker at international conferences, including Harvard, Columbia University, and the European Congress of Endocrinology. He has served as a peer reviewer for leading journals such as Science, Nature, and Cell Metabolism, further cementing his reputation as a global expert in obesity and metabolic disorders. His extensive contributions have also been recognized through significant research funding (~€2.5 million over the last decade) and multiple patents related to obesity treatment and metabolic health. These awards and honors reflect his exceptional influence in the scientific community.

Conclusion

Prof. Saverio Cinti is an internationally renowned researcher whose groundbreaking work in obesity and adipose tissue biology has significantly advanced the field. With an illustrious career spanning over four decades, he has contributed extensively through research, education, and leadership roles. His vast publication record, high citation impact, and numerous awards showcase his global influence. His research has led to new insights into fat metabolism, obesity treatment, and regenerative medicine, positioning him at the forefront of translational obesity research. His commitment to scientific excellence, combined with his mentorship and leadership roles, has inspired countless researchers worldwide. Moving forward, expanding interdisciplinary collaborations, integrating emerging technologies, and increasing public outreach could further enhance his already significant impact. Prof. Cinti’s contributions make him a strong candidate for the Best Researcher Award, reflecting his exceptional dedication to scientific progress and medical innovation.

Publications Top Notes

  • Title: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Authors: P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, …
    Year: 2012
    Citations: 5879

  • Title: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
    Authors: Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, …
    Year: 1999
    Citations: 4936

  • Title: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Authors: S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, …
    Year: 2005
    Citations: 3248

  • Title: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss
    Authors: R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, …
    Year: 2005
    Citations: 1498

  • Title: Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
    Authors: P. Seale, H.M. Conroe, J. Estall, S. Kajimura, A. Frontini, J. Ishibashi, P. Cohen, …
    Year: 2011
    Citations: 1482

  • Title: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice
    Authors: J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C. Zhang, V.K. Mootha, …
    Year: 2004
    Citations: 1465

  • Title: The adipose organ
    Authors: S. Cinti
    Year: 2007
    Citations: 1161

  • Title: βAR signaling required for diet-induced thermogenesis and obesity resistance
    Authors: E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, …
    Year: 2002
    Citations: 1079

  • Title: Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch
    Authors: P. Cohen, J.D. Levy, Y. Zhang, A. Frontini, D.P. Kolodin, K.J. Svensson, J.C. Lo, …
    Year: 2014
    Citations: 967

  • Title: The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
    Authors: G. Barbatelli, I. Murano, L. Madsen, Q. Hao, M. Jimenez, K. Kristiansen, …
    Year: 2010
    Citations: 948

  • Title: The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue
    Authors: M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, …
    Year: 2009
    Citations: 915

  • Title: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
    Authors: I. Murano, G. Barbatelli, V. Parisani, C. Latini, G. Muzzonigro, M. Castellucci, …
    Year: 2008
    Citations: 879